Diaceutics PLC announced revenue results for the six months ended 30 June 2023. For the period, the company reported revenue grew 32% to £9.9 million in against £7.5 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
118.5 GBX | +3.49% | +20.92% | +36.21% |
05-16 | EARNINGS AND TRADING: Michelmersh continues with positive order intake | AN |
05-16 | Diaceutics Bags Two Enterprise-wide Engagements with Large Pharmaceutical Companies | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.21% | 123M | |
+21.88% | 4.55B | |
-18.21% | 2.36B | |
+25.41% | 1.96B | |
-9.47% | 1.6B | |
-0.91% | 1.57B | |
-18.73% | 1.51B | |
-31.16% | 1.2B | |
-7.47% | 1.17B | |
-7.67% | 992M |
- Stock Market
- Equities
- DXRX Stock
- News Diaceutics PLC
- Diaceutics PLC Announces Revenue Results for the Six Months Ended 30 June 2023